Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer Interventions: Biological: Innocell Autologous Cellular Immunotherapy Sponsors: PhotonPharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Immunotherapy | Ovarian Cancer | Ovaries | Research